Latest Strategic Shift News

Field Solutions Holdings reports a neutral operating cashflow for Q2 2024, while navigating a trading halt and preparing for a capital raise alongside key business divestments.

Micro-X announces a strategic pivot towards medical imaging, anchored by a $25 million US government contract to develop a portable Full Body CT scanner, while discontinuing its Argus security operations to streamline costs.

Blackstone Minerals broadens its commodity focus to copper-gold assets while completing a key pilot program for battery-grade materials, positioning itself for growth amid evolving market dynamics.

Chariot Corporation pivots to a small-scale pilot mine strategy at its Black Mountain lithium project, backed by a $1.618 million capital raise and a new drilling phase to define near-term spodumene resources.

Flagship Minerals Limited has significantly expanded its Rosario Copper Project in Chile, revealing high-grade copper mineralisation and securing a $35 million equity investment to accelerate development.

Caprice Resources has launched a 5,000m drilling program at its Island Gold Project and expanded its West Arunta copper-niobium exploration tenure, supported by a $2.5 million capital raise. The company is sharpening its focus on high-grade gold assets in the Murchison goldfields while advancing large-scale greenfield projects.

AXP Energy reports a 12% decline in oil production but a 9% revenue increase, driven by strategic gas-to-power initiatives and a new joint development agreement.

X2M Connect reported a 51% revenue drop in Q2 FY25 as it shifts from hardware to SaaS, yet improved margins and EBITDA signal progress. Strategic partnerships in the Middle East and Taiwan offer promising growth avenues.

Pacific Nickel Mines Limited has paused its Kolosori Nickel Project due to operational setbacks and a challenging nickel price environment, entering voluntary suspension while negotiating critical financing with Glencore.

Clean TeQ Water Limited reports a landmark $11 million contract for its PHOSPHIX® phosphate removal plant in Ireland, alongside successful project deliveries and lithium recovery breakthroughs, setting the stage for improved financial performance in 2025.

Duxton Farms Limited reported a robust Q2 FY2025, driven by favourable weather conditions and strategic investments, including a share buyback and increased stakes in agricultural ventures. The company recorded a $2.24 million operating cash flow surplus amid mixed crop yields and ongoing diversification.

Prescient Therapeutics has secured FDA clearance for its PTX-100 Phase 2 trial targeting relapsed/refractory cutaneous T-cell lymphoma, while also appointing James McDonnell as its new CEO. The company reports steady progress in its cell therapy platforms and maintains a solid cash position bolstered by a recent R&D tax rebate.